The emerging approach of this peptide represents a significant development in the care of diabetes mellitus type 2. Unlike existing medications, tirzepatide impacts dual pathways – GLP-1 and GIP – leading to enhanced blood sugar management and anticipated reduction in weight. Researchers are exploring its long-term effects and part in the compl